Testing effectiveness (Phase 2)Ended earlyNCT02701517
What this trial is testing
Cyclosporine Plus Methotrexate or Alemtuzumab
Who this might be right for
Unrecognized Condition: Mature B or T-cell Neoplasm
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 72